4.5 Review

Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome

期刊

EUROPEAN RESPIRATORY REVIEW
卷 30, 期 161, 页码 -

出版社

EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/16000617.0059-2021

关键词

-

向作者/读者索取更多资源

Acute respiratory distress syndrome (ARDS) is a serious complication of severe systemic or local pulmonary inflammation, characterised by diffuse alveolar damage that leads to protein-rich pulmonary edema, local alveolar hypoventilation, and atelectasis. The main cause of hypoxemia in ARDS is inadequate perfusion in affected areas, with high perfusion in relation to ventilation and shunting being common. Balancing pulmonary vascular tone is a therapeutic challenge, with inhaled vasodilators showing some benefit in certain patient populations. Various novel treatment targets are being explored to improve perfusion in ARDS, while lung protective ventilation and prone positioning remain the standard of care.
Acute respiratory distress syndrome (ARDS) is a serious complication of severe systemic or local pulmonary inflammation, such as caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. ARDS is characterised by diffuse alveolar damage that leads to protein-rich pulmonary oedema, local alveolar hypoventilation and atelectasis. Inadequate perfusion of these areas is the main cause of hypoxaemia in ARDS. High perfusion in relation to ventilation (V/Q<1) and shunting (V/Q=0) is not only caused by impaired hypoxic pulmonary vasoconstriction but also redistribution of perfusion from obstructed lung vessels. Rebalancing the pulmonary vascular tone is a therapeutic challenge. Previous clinical trials on inhaled vasodilators (nitric oxide and prostacyclin) to enhance perfusion to high V/Q areas showed beneficial effects on hypoxaemia but not on mortality. However, specific patient populations with pulmonary hypertension may profit from treatment with inhaled vasodilators. Novel treatment targets to decrease perfusion in low V/Q areas include epoxyeicosatrienoic acids and specific leukotriene receptors. Still, lung protective ventilation and prone positioning arc the best available standard of care. This review focuses on disturbed perfusion in ARDS and aims to provide basic scientists and clinicians with an overview of the vascular alterations and mechanisms of V/Q mismatch, current therapeutic strategies, and experimental approaches.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据